TRAVERE THERAPEUTICS, INC. Payments to Acquire Equity Method Investments
TRAVERE THERAPEUTICS, INC. (TVTX) reported Payments to Acquire Equity Method Investments of $0 for the 12-month period ending 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireEquityMethodInvestments · last filed 2021-03-01
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for the quarter ending 2019-12-31 was $0.00.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for the quarter ending 2019-09-30 was $0.00.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for the quarter ending 2019-03-31 was $0.00, a 100.00% decline year-over-year.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for fiscal 2020 was $0.00.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for fiscal 2018 was $15.00M.
- TRAVERE THERAPEUTICS, INC. payments to acquire equity method investments for fiscal 2017 was $0.00.
| Period end | Payments to Acquire Equity Method Investments 3 month | Payments to Acquire Equity Method Investments 6 month | Payments to Acquire Equity Method Investments 9 month | Payments to Acquire Equity Method Investments 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | |||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 10-K · filed 2021-03-01 |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $0.00 derived: sum of 2 quarters · filed 2019-10-30 | $0.00 10-Q · filed 2019-10-30 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $0.00 10-Q · filed 2019-08-06 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $0.00 derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-07 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $0.00 derived: sum of 3 quarters · filed 2021-03-01 | $5.00M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $0.00 derived: sum of 2 quarters · filed 2021-03-01 | $5.00M derived: sum of 3 quarters · filed 2021-03-01 | $15.00M 10-K · filed 2021-03-01 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $5.00M derived: sum of 2 quarters · filed 2019-10-30 | $15.00M 10-Q · filed 2019-10-30 | $15.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-06-30 | $5.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $15.00M 10-Q · filed 2019-08-06 | $15.00M derived: sum of 3 quarters · filed 2020-02-24 | $15.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2018-03-31 | $10.00M 10-Q · filed 2019-05-07 | $10.00M derived: sum of 2 quarters · filed 2020-02-24 | $10.00M derived: sum of 3 quarters · filed 2020-02-24 | $10.00M derived: sum of 4 quarters · filed 2020-02-24 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $0.00 derived: sum of 2 quarters · filed 2020-02-24 | $0.00 derived: sum of 3 quarters · filed 2020-02-24 | $0.00 10-K · filed 2020-02-24 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $0.00 derived: sum of 2 quarters · filed 2018-11-01 | $0.00 10-Q · filed 2018-11-01 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-03 | $0.00 10-Q · filed 2018-08-03 | ||
| 2017-03-31 | $0.00 10-Q · filed 2018-07-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Erasca, Inc. (ERAS) | United States | $5.073B | -19.96 |
| Veradermics, Inc (MANE) | United States | $4.839B |